RedHill Biopharma Ltd (RDHL)

[midastouch017]

Redhill Biopharma Ltd. (RDHL) Given Average Recommendation of “Buy” by Brokerages

Posted by Toi Williams on Oct 6th, 2017

https://www.truebluetribune.com/2017/10/06/redhill-biopharma-ltd-rdhl-given-average-recommendation-of-buy-by-brokerages.html

Redhill Biopharma Ltd. (NASDAQ:RDHL) has received a consensus rating of “Buy” from the six analysts that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $31.50.
A number of equities research analysts recently weighed in on RDHL shares. HC Wainwright set a $33.00 price objective on shares of Redhill Biopharma and gave the company a “buy” rating in a research report on Wednesday, July 26th. Roth Capital set a $27.00 price target on shares of Redhill Biopharma and gave the stock a “buy” rating in a research note on Monday, July 31st. Zacks Investment Research lowered shares of Redhill Biopharma from a “hold” rating to a “sell” rating in a research note on Saturday, July 29th. Seaport Global Securities began coverage on shares of Redhill Biopharma in a research note on Friday. They set a “buy” rating for the company. Finally, FBR & Co restated a “buy” rating on shares of Redhill Biopharma in a research report on Friday, June 16th.